Molecular Data Inc. [NASDAQ: MKD] surged by $0.0 during the normal trading session on Monday and reaching a high of $0.3035 during the day while it closed the day at $0.29. The company report on September 22, 2021 that Molecular Data Inc. Closes $15 Million Registered Direct Offering.
Molecular Data Inc. (Nasdaq: MKD), a leading technology-driven platform in China’s chemical industry, announced it closed its previously announced registered direct offering for the purchase and sale of (i) common units, consisting of one American Depositary Share, or ADS, each representing three of its Class A ordinary shares, and one warrant to purchase one ADS and (ii) pre-funded units, consisting of one pre-funded warrant to purchase one ADS and one warrant to purchase one ADS. The purchase price of the common units was $0.38 per unit. The purchase price of the pre-funded units was $0.3799 per unit. The exercise price of the pre-funded warrants is $0.0001, and the exercise price of the ADS warrants is $0.38. The gross proceeds of the offering were approximately $15 million, before deducting placement agent fees and other estimated offering expenses. The Company intends to use the net proceeds for working capital and for other general corporate purposes.
Aegis Capital Corp. acted as sole lead placement agent for the offering.
Molecular Data Inc. stock has also loss -0.81% of its value over the past 7 days. However, MKD stock has declined by -68.96% in the 3 months of the year. Over the past six months meanwhile, it has lost -71.37% and lost -64.89% year-on date.
The market cap for MKD stock reached $42.51 million, with 116.90 million shares outstanding and 89.44 million shares in the current float. Compared to the average trading volume of 3.42M shares, MKD reached a trading volume of 14169065 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Molecular Data Inc. [MKD]:
The Average True Range (ATR) for Molecular Data Inc. is set at 0.04, with the Price to Sales ratio for MKD stock in the period of the last 12 months amounting to 0.04.
MKD stock trade performance evaluation
Molecular Data Inc. [MKD] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.81. With this latest performance, MKD shares dropped by -28.34% in over the last four-week period, additionally sinking by -71.37% over the last 6 months – not to mention a drop of -73.43% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MKD stock in for the last two-week period is set at 32.54, with the RSI for the last a single of trading hit 31.74, and the three-weeks RSI is set at 33.21 for Molecular Data Inc. [MKD]. The present Moving Average for the last 50 days of trading for this stock 0.4956, while it was recorded at 0.2922 for the last single week of trading, and 0.8976 for the last 200 days.
Molecular Data Inc. [MKD]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Molecular Data Inc. [MKD] shares currently have an operating margin of -4.36 and a Gross Margin at -0.13. Molecular Data Inc.’s Net Margin is presently recorded at -4.32.
Additionally, MKD Total Debt to Total Capital is recorded at 137.48, with Total Debt to Total Assets ending up at 14.96.
Reflecting on the efficiency of the workforce at the company, Molecular Data Inc. [MKD] managed to generate an average of -$251,431 per employee. Receivables Turnover for the company is 49.59 with a Total Asset Turnover recorded at a value of 12.55.Molecular Data Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.00 and a Current Ratio set at 1.00.
Molecular Data Inc. [MKD]: Insider Ownership positions
There are presently around $2 million, or 4.50% of MKD stock, in the hands of institutional investors. The top three institutional holders of MKD stocks are: TB ALTERNATIVE ASSETS LTD. with ownership of 5,000,000, which is approximately 0% of the company’s market cap and around 10.08% of the total institutional ownership; VIRTU FINANCIAL LLC, holding 179,766 shares of the stock with an approximate value of $53000.0 in MKD stocks shares; and CITADEL ADVISORS LLC, currently with $50000.0 in MKD stock with ownership of nearly -38.979% of the company’s market capitalization.
Positions in Molecular Data Inc. stocks held by institutional investors increased at the end of September and at the time of the September reporting period, where 3 institutional holders increased their position in Molecular Data Inc. [NASDAQ:MKD] by around 48,102 shares. Additionally, 8 investors decreased positions by around 697,255 shares, while 2 investors held positions by with 4,676,373 shares. The mentioned changes placed institutional holdings at 5,421,730 shares, according to the latest SEC report filing. MKD stock had 1 new institutional investments in for a total of 10,098 shares, while 5 institutional investors sold positions of 550,388 shares during the same period.